Many of the early rapid responses to the DAFNE trial paper (1) [see bmj.com] claimed that improved quality of life (QoL) resulting from flexible intensified insulin treatment was well established prior to the DAFNE trial (Ullman, 5th Oct; Black, 6th Oct; Chaufan, 12th Oct). However, the only evidence cited was anecdotal.
|Place of Publication||Egham, UK|
|Publisher||British Medical Journal|
|Publication status||Published - 6 Nov 2002|
- Quality of Life
- Insulin treatment